首頁 > 市場調查報告書 > 製藥

藥物開發

市場調查報告書

商品編碼

1534255

全球藥物發現資訊學市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Drug Discovery Informatics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球藥物發現資訊學市場需求預計將從 2023 年的 37.8 億美元達到 2032 年近 103.7 億美元的市場規模，2024-2032 年研究期間複合年成長率為 11.86%。

藥物發現資訊學涉及計算和資訊技術的應用來加速藥物發現和開發過程。它包括一系列工具和平台，旨在促進藥物發現各個階段的資料管理、分析和視覺化——從標靶識別和驗證到先導化合物最佳化和臨床前測試。它整合了生物資訊學、化學資訊學、分子建模和系統生物學方法，以提高效率、降低成本並提高藥物發現專案的成功率。透過利用人工智慧、巨量資料分析和機器學習演算法，資訊學平台使研究人員能夠分析大量資料集，預測化合物活性，並優先考慮候選藥物進行實驗驗證，從而簡化新療法的發現。

市場動態

將新藥推向市場的複雜性和成本不斷增加，以及對創新療法來解決未滿足的醫療需求的需求，推動了對資訊學解決方案的需求。藥物發現資訊學使製藥公司和研究機構能夠加快識別有前途的候選藥物、最佳化分子結構並更準確地預測藥理特性。運算方法和高效能運算能力的進步增強了資訊學平台的能力。人工智慧和機器學習演算法的整合改進了預測建模、虛擬篩選和分子動力學模擬，從而加速了先導化合物的識別，並減少了臨床前研究所需的時間和資源。此外，大規模生物和化學資料集（包括基因組資料、蛋白質組資料和化合物庫）的可用性不斷增加，為藥物發現資訊學提供了機會。資訊學工具使研究人員能夠挖掘這些資料集以獲得新的見解、生物標記發現和個人化醫療應用，從而促進整個製藥業的協作和創新。然而，不同資訊學平台和專有資料庫之間的互通性挑戰和資料整合複雜性是藥物發現資訊學市場成長的重大障礙。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球藥物發現資訊學市場的每個細分市場進行包容性評估。藥物發現資訊學產業的成長和趨勢為這項研究提供了一種整體方法。

市場區隔

藥物發現資訊學市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按工作流程

發現資訊學
生物內容管理

按服務分類

序列分析平台
分子模擬
對接
臨床試驗數據管理
其他

區域分析

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲藥物發現資訊學市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。藥物發現資訊學市場的主要參與者包括 Certara、勃林格殷格翰國際有限公司、Infosys Ltd.、Charles River Laboratories、Collaborative Drug Discovery Inc.、Eurofins DiscoverX Products、Jubliant Biosys、Selvita、Novo Informatics Pvt.。 Ltd.、ChemAxon Ltd.、奧爾巴尼分子研究公司、甲骨文、埃森哲、安捷倫科技公司、Illumina 公司。財務概覽、合作、新產品開發、新產品發布和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：藥物發現資訊學公司的競爭格局

藥物發現資訊學市場競賽
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Certara

公司概況
公司收入
產品
最新動態

Boehringer Ingelheim International GmbH

公司概況
公司收入
產品
最新動態

Infosys Ltd.

公司概況
公司收入
產品
最新動態

Charles River Laboratories

公司概況
公司收入
產品
最新動態

Collaborative Drug Discovery Inc.

公司概況
公司收入
產品
最新動態

Eurofins DiscoverX Products

公司概況
公司收入
產品
最新動態

Jubliant Biosys

公司概況
公司收入
產品
最新動態

Selvita

公司概況
公司收入
產品
最新動態

Novo Informatics Pvt. Ltd.

公司概況
公司收入
產品
最新動態

ChemAxon Ltd.

公司概況
公司收入
產品
最新動態

Albany Molecular Research Inc.

公司概況
公司收入
產品
最新動態

Oracle

公司概況
公司收入
產品
最新動態

Accenture

公司概況
公司收入
產品
最新動態

Agilent Technologies Inc.

公司概況
公司收入
產品
最新動態

Illumina Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115285

The global demand for Drug Discovery Informatics Market is presumed to reach the market size of nearly USD 10.37 Billion by 2032 from USD 3.78 Billion in 2023 with a CAGR of 11.86% under the study period 2024-2032.

Drug discovery informatics involves the application of computational and informational technologies to accelerate the drug discovery and development process. It includes a range of tools & platforms designed to facilitate data management, analysis, and visualization across various stages of drug discovery-from target identification and validation to lead optimization and preclinical testing. It integrates bioinformatics, cheminformatics, molecular modeling, and systems biology approaches to enhance efficiency, reduce costs, and improve the success rate of drug discovery programs. By leveraging artificial intelligence, big data analytics, and machine learning algorithms, informatics platforms enable researchers to analyze vast datasets, predict compound activities, and prioritize candidates for experimental validation, thereby streamlining the discovery of novel therapeutics.

MARKET DYNAMICS

The increasing complexity and cost of bringing new drugs to market and the need for innovative therapies to address unmet medical needs drive demand for informatics solutions. Drug discovery informatics enables pharmaceutical companies and research institutions to expedite the identification of promising drug candidates, optimize molecular structures, and predict pharmacological properties more accurately. Advancements in computational methodologies and high-performance computing capabilities enhance the capabilities of informatics platforms. Integrating AI and machine learning algorithms improves predictive modeling, virtual screening, and molecular dynamics simulations, thereby accelerating the identification of lead compounds and reducing the time and resources required for preclinical studies. Moreover, the growing availability of large-scale biological and chemical datasets, including genomics data, proteomics data, and compound libraries, presents opportunities for drug discovery informatics. Informatics tools enable researchers to mine these datasets for novel insights, biomarker discovery, and personalized medicine applications, fostering collaboration and innovation across the pharmaceutical industry. However, interoperability challenges and data integration complexities across diverse informatics platforms and proprietary databases are significant barriers to drug discovery informatics market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Drug Discovery Informatics. The growth and trends of Drug Discovery Informatics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Drug Discovery Informatics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Workflow

Discovery Informatics
Biocontent Management

By Services

Sequence Analysis Platforms
Molecular Modelling
Docking
Clinical Trial Data Management
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drug Discovery Informatics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Discovery Informatics market include Certara, Boehringer Ingelheim International GmbH, Infosys Ltd., Charles River Laboratories, Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Jubliant Biosys, Selvita, Novo Informatics Pvt. Ltd., ChemAxon Ltd., Albany Molecular Research Inc., Oracle, Accenture, Agilent Technologies Inc., Illumina Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. DRUG DISCOVERY INFORMATICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Workflow
- 3.7.2 Market Attractiveness Analysis By Services
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY WORKFLOW

5.1. Overview By Workflow
5.2. Historical and Forecast Data Analysis By Workflow
5.3. Discovery Informatics Historic and Forecast Sales By Regions
5.4. Biocontent Management Historic and Forecast Sales By Regions

6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY SERVICES

6.1. Overview By Services
6.2. Historical and Forecast Data Analysis By Services
6.3. Sequence Analysis Platforms Historic and Forecast Sales By Regions
6.4. Molecular Modelling Historic and Forecast Sales By Regions
6.5. Docking Historic and Forecast Sales By Regions
6.6. Clinical Trial Data Management Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE DRUG DISCOVERY INFORMATICS COMPANIES

8.1. Drug Discovery Informatics Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF DRUG DISCOVERY INFORMATICS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Certara
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Boehringer Ingelheim International GmbH
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Infosys Ltd.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Charles River Laboratories
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Collaborative Drug Discovery Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Eurofins DiscoverX Products
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Jubliant Biosys
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Selvita
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Novo Informatics Pvt. Ltd.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. ChemAxon Ltd.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Albany Molecular Research Inc.
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. Oracle
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments
9.15. Accenture
- 9.15.1 Company Overview
- 9.15.2 Company Revenue
- 9.15.3 Products
- 9.15.4 Recent Developments
9.16. Agilent Technologies Inc.
- 9.16.1 Company Overview
- 9.16.2 Company Revenue
- 9.16.3 Products
- 9.16.4 Recent Developments
9.17. Illumina Inc
- 9.17.1 Company Overview
- 9.17.2 Company Revenue
- 9.17.3 Products
- 9.17.4 Recent Developments